Nowadays, both pharmacological and non-pharmacological options are used to treat the depression. Most often a patient is offered either pharmacological or the combined treatment consisting of antidepressant
medication and psychotherapy, which really works, but, unfortunately, not for everyone.
If the patient does not respond to medication or can not tolerate the side effects of medication, rTMS therapy becomes an alternative.
Magnetic stimulators can perform stimulation of dorsal prefrontal cortex (DLPFC).
It impacts the mood stabilizers, thus, the long-lasting therapeutic effect, non-invasive, with no pain and minimum contraindications is achieved.
According to the results of the clinical trials, the number of responders to rTMS therapy in antidepressant treatment-resistant patients is about 50%.
At that, depending on the depression type the remission is reached in every second* patient.
Meet Our Team